SPP100

DRUG2 trials

Sponsors

Novartis, Noden Pharma

Conditions

Hypertension

Phase 2

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

CompletedNCT00246584

NovartisHypertension

Start: 2004-10-31Target: 300Updated: 2006-07-28

Unknown Phase

52-104 Week Off-therapy Second Extension to Study CSPP100A2365

CompletedNCT01420068

Noden PharmaHypertension

Start: 2011-08-19End: 2017-08-03Updated: 2019-03-19